Context Therapeutics Inc.
CNTX
$0.784
$0.0111.42%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.34M | -17.46M | -2.25M | -3.67M | -6.77M |
| Total Depreciation and Amortization | 2.90K | 2.80K | 2.60K | 2.60K | 2.60K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 257.10K | 14.98M | 157.00K | 240.00K | 256.10K |
| Change in Net Operating Assets | -1.82M | 544.20K | -1.26M | -935.40K | -715.90K |
| Cash from Operations | -4.91M | -1.93M | -3.36M | -4.36M | -7.23M |
| Capital Expenditure | 0.00 | -7.30K | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -14.75M | -- | -- | -- |
| Cash from Investing | 0.00 | -14.76M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 14.54M | -- | 94.80M | -- | -- |
| Repurchase of Common Stock | -- | -44.60K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 14.54M | -44.60K | 94.80M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 9.63M | -16.74M | 91.45M | -4.36M | -7.23M |